Original Source(s)
Related Content
This Week's CGT News: First Treg Therapy Approved
First Treg-based cell therapy approved, FDA advanced therapy office faces fresh turnover, and preclinical CAR T studies target rare blood cancers and glioblastoma
July 7, 2026
-
6 min
Study explores adding a low-dose, daily oral chemotherapy for patients with melanoma
UCI Health medical oncologist Poorva Vaidya, MD is currently offering a new clinical trial sponsored by the UC Irvine Anti-Cancer Challenge, and lead by Warren Chow, MD, aimed at tackling a persistent challenge in melanoma care if patients fail first-line immunotherapy.
June 24, 2026
-
1 min
Inside VIVEbiotech’s Work with Zelluna on TCR-NK Cell Therapy
VIVEbiotech CEO Jon Alberdi lifts the lid on an eight-year collaboration focused on GMP lentiviral vectors for off-the-shelf solid tumor therapies
July 14, 2026
-
4 min